Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Topical IKKα inhibitors may help prevent CCS tumours.

Vitamin D receptor may help protect against UV-induced skin cancer.

Neuregulin3 affects cell development in the skin and mammary glands.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The vitamin D receptor can work without its usual activating molecule.

Lack of KSR1 stops certain skin tumors in mice.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Vitamin D receptor helps prevent skin cancer and supports skin health.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

RNase L hinders hair growth by altering immune signals.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

AMPK activation may reduce melanoma risk in red-haired individuals.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

SOX4 is crucial for the development of melanoma.